Vitamin K and vascular calcifications

Acta Physiologica Hungarica

Volumn 97, Issue 3, 2010, Pages 256-266

  Fodor, Daniela ^a,b,c   Albu, A ^a   Poanta L ^a   Porojan, M ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Clinica Medical   (Romania)

^c NONE   (Romania)

Author keywords

matrix Gla protein; vascular calcification; vitamin K 1; vitamin K dependent proteins

Indexed keywords

ALKALINE PHOSPHATASE; ANKYLOSIS PROTEIN; ANTICOAGULANT AGENT; ANTIVITAMIN K; COUMARIN DERIVATIVE; ENZYME; FARNOQUINONE; FETUIN A; GROWTH ARREST SPECIFIC PROTEIN 6; MATRIC GLA PROTEIN; MENAQUINONE; MENATETRENONE; NUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN; PHOSPHODIESTERASE; PHYTOMENADIONE; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG; VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1; VITAMIN K GROUP; WARFARIN; CALCIUM BINDING PROTEIN; MATRIX GLA PROTEIN; SCLEROPROTEIN;

AORTA VALVE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; BONE METABOLISM; CARDIOVASCULAR FUNCTION; CARTILAGE; DRUG ACCUMULATION; DRUG TRANSPORT; GENETIC POLYMORPHISM; HEART VALVE; HUMAN; MITRAL VALVE; MORBIDITY; MORTALITY; NONHUMAN; PROTEIN FUNCTION; SHEAR STRESS; THROMBOSIS; TUNICA MEDIA; VITAMIN K METABOLISM; ANIMAL; BLOOD CLOTTING; CALCINOSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR DISEASE;

ANIMALS; BLOOD COAGULATION; CALCINOSIS; CALCIUM-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; VASCULAR DISEASES; VITAMIN K;

EID: 77957084865     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.97.2010.3.2     Document Type: Article

References (56)

1. Abedin M, Tintut Y, Demer LL: Vascular calcification. Mechanisms and clinical ramifications. Arterioscler. Thromb. Biol. 24, 1161-1170 (2004)
2. Berkner KL, Runge KW: The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J. Tromb. Haemost. 2, 2118-2132 (2004)
3. Boon A, Cheriex E, Lodder J, Kessels F: Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 78, 472-474 (1997) (Pubitemid 27515107)
4. Booth SL, Lichtenstein AH, Dallal G: Phylloquinone absorption from phylloquinone-fortified oil is greater than from a vegetable in younger and older men and women. J. Nutr. 132, 2609-2612 (2002)
5. Boström K, Tsao D, Shen S, Wang Y, Demer LL: Matrix Gla protein modulates differentiation induced by bone morphogeneic protein-2 (BMP-2) in C3H10T1/2 cells. J. Biol. Chem. 276, 14044-14052 (2001)
6. Cranenburg EC, Schurgers LJ, Vermeer C: Vitamin K: the coagulation vitamin that became omnipotent. Thromb. Haemost. 98, 120-125 (2007)
7. Cranenburg EC, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, Kwaijtaal M, Brandenburg VM, Ketteler M, Schurgers LJ: The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J. Vasc. Res. 45, 427-436 (2008)
8. Danilevicius CF, Lopes JB, Pereira RMR: Bone metabolism and vascular calcification. Braz. J. Med. Biol. Res. 40, 435-442 (2007)
9. Davidson RT, Foley AL, Engelke JA, Suttie JW: Conversion of dietary phylloquinone to tissue menaquinones-4 in rats is not dependent on gut bacteria. J. Nutr. 128, 220-223 (1998)
10. Dobrin B: Mechanical factors associated with the development of intimal and medial thickening in vein grafts subjected to arterial pressure: a model of arteries exposed to hypertension. Hypertension 26, 3-43 (1995)
11. Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, Shah PK, Rajavashisth TB: Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocrin. Rev. 25, 629-672 (2004)
12. Engelse MA, Neele JM, Bronckers AL, Pannekoek H, de Vries CJ: Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix Gla protein in human atherogenesis. Cardiovasc. Res. 52, 281-289 (2001)
13. Food and Nutrition Board Institute of Medicine (2001). Dietary reference intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press, Washington, DC, USA
14. Gast GC, de Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, Witteman JC, Grobbee DE, Peeters PH, van der Schouw YT: High menaquinone intake reduces the incidence of coronary heart disease. Nutr. Metab. Cardivasc. Dis. 19, 504-510 (2009)
15. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC: Dietary intake of menaquinones is associated with a reduced risk of coronary heart disease: the Rotterdam study. J. Nutr. 134, 3100-3105 (2004)
16. Goodman WG: Vascular calcification in chronic renal failure. Lancet 358, 1115-1116 (2001)
17. Hall JG, Pauli RM, Wilson KM: Maternal and fetal sequelae of anticoagulation during pregnancy. Am. J. Med. 68, 122-140 (1980)
18. Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H: Vascular calcification and osteoporosis - from clinical observation towards molecular understanding. Osteoporosis 18, 251-259 (2007)
19. Hruska KA, Mathew S, Saab G: Bone morphogenetic proteins in vascular calcification. Circ. Res. 97, 105-114 (2005)
20. Jie KS, Bots ML, Vermeer C, Witteman JC, Grobbee DE: Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. Atherosclerosis 116, 117-123 (1995)
21. Kapustin A, Shanahan CM: Targeting vascular calcification: softening-up a hard target. Current Opinion in Pharmacology 9, 84-89 (2009)
22. Koos R, Mahnken AH, Mühlenbruch G, Brandenburg V, Pflueger B, Wildberger JE, Kühl HP: Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am. J. Cardiol. 96, 747-749 (2005)
23. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78-81 (1997)
24. McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR: Osteoporosis and cardiovascular disease: brittle bones and boned arteries - is there a link? Endocrine 23, 1-10 (2004)
25. Murshed M, Schinke T, McKee MD, Karsenty G: Extracellular matrix mineralization is regulated locally; different roles of two Gla-containing proteins. J. Cell Biol. 165, 625-630 (2004)
26. Nimptsch K, Nieters A, Hailer S, Wolfram G, Linseisen J: The association between dietary vitamin K intake and serum undecarboxylated osteocalcin is modulated by vitamin K epoxide reductase genotype. Br. J. Nutr. 25, 1-9 (2008)
27. Okano T, Shimomura Y, Yamane M, Suhara Y, Kamao M, Sugiura M, Nakagawa K: Conversion of phylloquinone (Vitamin K1) into menaquinones-4 (Vitamin K2) in mice: two possible routes for menaquinones-4 accumulation in cerebra of mice. J. Biol. Chem. 283, 11270-11279 (2008)
28. Parker BD, Ix JH, Cranenburg EC, Vermeer C, Whooley MA, Schurgers LJ: Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study. Nephrol. Dial. Transplant. 24, 2095-2101 (2009)
29. Pauli RM, Lian JB, Mosher DF, Suttie JW: Association of congenital deficiency multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embriopathy: clue to the mechanism of teratogenicity of coumarin derivatives. Am. J. Hum. Gen. 41, 566-583 (1987)
30. Presnell SR, Stafford DW: The vitamin K-dependent carboxylase. Thromb. Haemost. 87, 937-947 (2002)
31. Price PA, Faus SA, Wiliamson MK: Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arteriscler. Thromb. Vasc. Biol. 20, 317-327 (2000)
32. Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE: Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N. Engl. J. Med. 352, 2285-2293 (2005)
33. Rogers NM, Teubner DJ, Coates PT: Calcific uremic arteriolopathy: advances in pathogenesis and treatment. Semin. Dial. 20, 150-157 (2007)
34. Ross R: Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999)
35. Schurgers LJ, Aebert H, Vermeer C, Bültmann B, Janzen J: Oral anticoagulant treatment: friend or foe in cardiovascular diseases? Blood 104, 3231-3232 (2004)
36. Schurgers LJ, Cranenburg ECM, Vermeer C: Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thromb. Haemost. 100, 593-603 (2008)
37. Schurgers LJ, Geleijnse JM, Grobbee DE, Pols HAP, Hofman A, Witteman JCM, Vermeer C: Nutritional intake of vitamin K1 (phylloquinone) and K2 (menaquinone) in the Netherlands. J. Nutr. Environ. Med. 9, 115-122 (1999)
38. Schrugers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C: Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109, 2823-2831 (2007)
39. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C: Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arteriscler. Thromb. Vasc. Biol. 25, 1629-1633 (2005)
40. Schurgers LJ, Vermeer C: Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim. Biophys. Acta. 1570, 27-32 (2002)
41. Shanahan CM: Mechanisms of vascular calcification in renal disease. Clin. Nephrol. 63, 146-157 (2005)
42. Spronk HMH: Vitamin K epoxide reductase complex and vascular calcification. Is this the important link between vitamin K and arterial vessel wall? Circulation 113, 1550-1552 (2006)
43. Spronk HM, Soute BA, Schrugers LJ, Cleutjens JP, Thijssen HH, De Mey JG, Vermeer C: Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of arterial vessel wall. Biochem. Biophys. Res. Commun. 289, 485-490 (2001)
44. Spronk MH, Soute SA, Schrugers LJ, Thijssen HH, De Mey JG, Vermeer C: Tissue-specific utilization of menaquinones-4 results in the prevention of arterial calcification in warfarin-treated rats. J. Vasc. Res. 40, 531-537 (2003)
45. Stafford DW: The vitamin K cycle. J. Thromb. Haemost. 3, 1873-1878 (2005)
46. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ. Res. 89, 1147-1154 (2001)
47. Suhara Y, Wada A, Okano T: Elucidation of the mechanism producing menaquinones-4 in osteoblastic cells. Bioorg. Med. Chem. Lett. 2009, doi:10.1016/j.bmcl.2009.01.021.
48. Sweatt A, Sane DC, Hutson SM, Wallin R: Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J. Thromb. Haemost. 1, 178-185 (2003)
49. Thijssen HH, Drittij-Reijnders MJ: Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinones-4. Br. J. Nutr. 75, 121-127 (1996)
50. Van Winckel M, De Bruyne R, Van De Velde S, Van Biervlit S: Vitamin K, an update for the paediatrician. Eur. J. Pediatr. 168, 127-134 (2009)
51. Vattikuti R, Towler DA: Osteogenetic regulation of vascular calcification: an early perspective. Am. J. Psyhiol. Endocrinol. Metabol. 286, E686-E696 (2004)
52. Vermeer C, Shearer MJ, Zittermann A, Bolton-Smith C, Szulc P, Hodges S, Walter P, Rambeck W, Stöcklin E, Weber P: Beyond deficiency: Potential benefits of increased intakes of vitamin K for bone and vascular health. Eur. J. Nutr. 43, 325-335 (2004)
53. Wallin R, Schurgers L, Wajin N: Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb. Res. 122, 411-417 (2008)
54. Wang Y, Zhang W, Zhang Y, Yang Y, Sun L, Hu S, Chen J, Zhang C, Zheng Y, Zhen Y, Sun K, Fu C, Yang T, Wang J, Sun J, Wu H, Glasgow WC, Hui R: VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113, 1612-1625 (2006)
55. Yagami K, Suh JY, Enomoto-Iwamoto M, Koyama E, Abrams WR, Shapiro IM, Pacifici M, Iwamoto M: Matrix Gla protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J. Cell. Biol. 147, 1097-1108 (1999)
56. Yuan HY, Chen JJ, Lee MT, Wung JC, Chen YF, Charng MJ, Lu MJ, Hung CR, Wei CY, Chen CH, Wu JY, Chen YT: A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum. Mol. Genet. 14, 1745-1751 (2005)